Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Novo Nordisk A/S
Marc P Bonaca; Andrei-Mircea Catarig; Kim Houlind; Bernhard Ludvik; Joakim Nordanstig; Chethana Kalmady Ramesh; Neda Rasouli; Harald Sourij; Alex Videmark; Subodh Verma; STRIDE Trial Investigators